Clinical trials
13 active studies led by Taiho Oncology, Inc., of 66 in all
Source: ClinicalTrials.gov, Studies with Taiho Oncology, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Free public records show Taiho Oncology, Inc. in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by Taiho Oncology, Inc. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
13 active studies led by Taiho Oncology, Inc., of 66 in all
Source: ClinicalTrials.gov, Studies with Taiho Oncology, Inc. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
3 approvals with a product on the US market
Source: Drugs@FDA, Approvals (NDA, ANDA, BLA) held, with a product sold now; newest shown. Retrieved 13 Nov 2026.
Studies Taiho Oncology, Inc. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with Taiho Oncology, Inc. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show Taiho Oncology, Inc.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets Taiho Oncology, Inc. is in.
Stories on the topics Taiho Oncology, Inc. works in.
1.71 billion people live with musculoskeletal conditions, including 528 million with osteoarthritis. Evidence…
Read
Vitamin D is made in sunlight, yet low levels are common even in sunny countries. How much you need, and when…
Read
Collagen powders promise younger skin and easier joints. A 2025 review of 23 trials found the benefits…
Read